AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Parkinson Disease

Showing 71 to 80 of 503 articles

Clear Filters

Convolutional neural network based detection of early stage Parkinson's disease using the six minute walk test.

Scientific reports
The heterogeneity of Parkinson's disease (PD) presents considerable challenges for accurate diagnosis, particularly during early-stage disease, when the symptoms may be extremely subtle. This study aimed to assess the accuracy of a convolutional neur...

Late feature fusion using neural network with voting classifier for Parkinson's disease detection.

BMC medical informatics and decision making
Parkinson's disease (PD) is classified as a neurological, progressive illness brought on by cell death in the posterior midbrain. Early PD detection will assist doctors in reducing the disease's consequences. A collection of skilled models that may b...

Early Detection of Parkinson's Disease Using Deep NeuroEnhanceNet With Smartphone Walking Recordings.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society
With the development of digital medical technology, ubiquitous smartphones are emerging as valuable tools for the detection of complex and elusive diseases. This paper exploits smartphone walking recording for early detection of Parkinson's disease (...

Instrumented timed up and go test and machine learning-based levodopa response evaluation: a pilot study.

Journal of neuroengineering and rehabilitation
BACKGROUND: The acute levodopa challenge test (ALCT) is a universal method for evaluating levodopa response (LR). Assessment of Movement Disorder Society's Unified Parkinson's Disease Rating Scale part III (MDS-UPDRS III) is a key step in ALCT, which...

PD-ARnet: a deep learning approach for Parkinson's disease diagnosis from resting-state fMRI.

Journal of neural engineering
. The clinical diagnosis of Parkinson's disease (PD) relying on medical history, clinical symptoms, and signs is subjective and lacks sensitivity. Resting-state fMRI (rs-fMRI) has been demonstrated to be an effective biomarker for diagnosing PD.This ...

The Role of Deep Learning and Gait Analysis in Parkinson's Disease: A Systematic Review.

Sensors (Basel, Switzerland)
Parkinson's disease (PD) is the second most common movement disorder in the world. It is characterized by motor and non-motor symptoms that have a profound impact on the independence and quality of life of people affected by the disease, which increa...

Cognitive activity analysis of Parkinson's patients using artificial intelligence techniques.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
PURPOSE: The development of modern Artificial Intelligence (AI) based models for the early diagnosis of Parkinson's disease (PD) has been gaining deep attention by researchers recently. In particular, the use of different types of datasets (voice, ha...

Machine learning-based classification of Parkinson's disease using acoustic features: Insights from multilingual speech tasks.

Computers in biology and medicine
This study advances the automation of Parkinson's disease (PD) diagnosis by analyzing speech characteristics, leveraging a comprehensive approach that integrates a voting-based machine learning model. Given the growing prevalence of PD, especially am...

Sex-Specific Imaging Biomarkers for Parkinson's Disease Diagnosis: A Machine Learning Analysis.

Journal of imaging informatics in medicine
This study aimed to identify sex-specific imaging biomarkers for Parkinson's disease (PD) based on multiple MRI morphological features by using machine learning methods. Participants were categorized into female and male subgroups, and various struct...

Aging-related biomarkers for the diagnosis of Parkinson's disease based on bioinformatics analysis and machine learning.

Aging
Parkinson's disease (PD) is a multifactorial disease that lacks reliable biomarkers for its diagnosis. It is now clear that aging is the greatest risk factor for developing PD. Therefore, it is necessary to identify novel biomarkers associated with a...